IGC
India Globalization Capital Inc
NYSE MKT: IGC · HEALTHCARE · BIOTECHNOLOGY
$0.32
+3.16% today
Updated 2026-04-30
Market cap
$31.63M
P/E ratio
—
P/S ratio
28.60x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$0 – $1
Volume
1.2M
India Globalization Capital Inc (IGC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,518.00%
ROE
-83.30%
ROA
-50.30%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | $-765000.00 | $1.52M | 100.00% | 100.01% | -198.43% |
| 2008 | $2.19M | $-5.21M | 15.84% | 0.23% | -238.35% |
| 2009 | $35.34M | $-522000.00 | 20.62% | 10.78% | -1.48% |
| 2010 | $17.90M | $-4.79M | 12.44% | -22.30% | -26.76% |
| 2011 | $4.07M | $-20.24M | 3.91% | -194.13% | -496.83% |
| 2012 | $4.20M | $-7.75M | -14.71% | -178.86% | -184.57% |
| 2013 | $8.03M | $-2.25M | 19.09% | -30.93% | -28.04% |
| 2014 | $2.27M | $-3.02M | 16.79% | -111.22% | -133.00% |
| 2015 | $7.68M | $-4.61M | 7.55% | -56.54% | -60.08% |
| 2016 | $6.37M | $-2.81M | 13.24% | -45.64% | -44.10% |
| 2017 | $580372.00 | $-1.87M | 37.60% | -353.91% | -321.69% |
| 2018 | $2.19M | $-1.79M | 3.72% | -81.58% | -81.44% |
| 2019 | $5.12M | $-4.10M | 2.58% | -90.75% | -80.08% |
| 2020 | $4.07M | $-7.32M | 2.82% | -168.57% | -179.64% |
| 2021 | $898000.00 | $-8.81M | -38.86% | -971.49% | -981.18% |
| 2022 | $397000.00 | $-15.02M | 48.87% | -3,886.15% | -3,782.37% |
| 2023 | $911000.00 | $-11.51M | -17.34% | -1,270.14% | -1,263.01% |
| 2024 | $1.34M | $-13.00M | 54.50% | -728.48% | -966.54% |
| 2025 | $1.27M | $-7.12M | 48.70% | -585.84% | -560.27% |
| 2026 | $869000.00 | $-4.15M | 34.18% | -891.25% | -477.10% |